Karl Maria Schumacher, MD, Privat Dozent

About

- Development of proprietary AI-driven Probability of Success algorithm for oncology drug development -20+ years in oncology clinical development (targeted therapies, radio-conjugates, biosimilars

Experience

• Consultant at Freelance | Self-Employed
  Dec 2025 - Present · 7 mos

  🎯 Oncology Clinical Development | AI-Driven PoS Analytics | Open to Collaboration & Leadership Roles 🔹 Developed proprietary AI-powered PoS (Probability of Success) algorithm (490+ cases, 18 predictors, validated against TIGIT/SERD/ADC trials). Seeking investors/pharma/biotech partners to expand and commercialize. Available for consulting or Clinical Lead roles (all phases). 🔹 20+ years oncology development expertise: Targeted therapies, ADCs, radio- conjugates, biosimilars. VP/CMO-level strategic leadership in protocol design, regulatory strategy, portfolio optimization. 🔹 Building AI medical monitoring chatbot for real-time safety surveillance and clinical decision support. Looking for AI/ML engineers and pilot partners to co-develop. 🔹 Collaboration-focused: Open to research partnerships, joint ventures, and clinical leadership positions. Let's innovate together.

• Director Clinical Development at Full-Life Technologies
  Mar 2024 - Nov 2025 · 1 yr 9 mos

• Consultant at OncInnovat KmS GmbH
  Jun 2023 - Feb 2024 · 9 mos

  Tasks ranging from Chief Clinical Officer to Medical Monitor (Clinical Development Oncology)

• Chief Medical Officer at TOLREMO therapeutics AG
  Jun 2022 - May 2023 · 1 yr

• Merck Gruppe (3 yrs 2 mos)
  • Vice President Clinical Development
    Jun 2021 - May 2022 · 1 yr

    Head Targeted Therapies Oncology

  • Executive Medical Director
    Apr 2019 - May 2021 · 2 yrs 2 mos

    Clinical Lead Tepotinib